Results for this period
Full year1 April 2025–31 March 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ million).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
Revenue declined due to weak sales of nylon polymers, caprolactam and other products, and the exclusion of the steelmaking business from the scope of consolidation, despite the contribution from the acquisition of the Urethane Systems business. Operating profit increased due to lower depreciation and amortization resulting from the business structure reform-related impairment loss recorded in the previous fiscal year, the absence of a periodic maintenance shutdown at the ammonia plant, and lower elastomer raw material prices. Net income attributable to owners of the parent increased because the extraordinary losses related to business structure reform recorded in the previous fiscal year did not recur in the current fiscal year.
Not applicable.
| Item | Details |
|---|---|
| Fiscal Period Classification | Full year |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 April 2025–31 March 2026 |
| Net Sales | ¥462,343 million (YoY -5.0%) |
| Operating profit | ¥18,941 million (YoY +5.0%) |
| Ordinary income | ¥37,506 million (YoY +67.7%) |
| Profit attributable to owners of the parent | ¥23,872 million |
| Net income per share | ¥245.76 |
| Operating Margin | 4.1 |
| Equity ratio | End of the current fiscal period 46.2 / End of previous period 45.6 |
| Total assets | ¥946,313 million |
| Net assets | ¥454,934 million |
| Cash flows from operating activities | ¥59,984 million |
| Cash flows from investing activities | ¥-140,232 million |
| Cash flows from financing activities | ¥13,027 million |
| Cash and cash equivalents at end of period | ¥52,583 million |
| Full-year earnings forecast | Net Sales ¥485,000 million (YoY +4.9%) / Operating profit ¥23,500 million (YoY +24.1%) / Ordinary income ¥37,500 million (YoY -0.0%) / Net income ¥24,500 million (YoY +2.6%) |
| Annual Dividend Forecast | ¥110 → To be determined（To be determined） |
| Payout ratio | 44.8 |
| Shareholder Return Policy | DOE (dividend on equity ratio) of at least 2.5%. However, the company is reviewing its dividend policy, including the DOE level. |
| Segment revenue | Functional products ¥619 100 million (YoY -6.4%), High-performance urethane ¥465 100 million (YoY +198.1%), Pharmaceuticals ¥210 100 million (YoY -33.3%), Resins and chemicals ¥2,512 100 million (YoY -8.2%), Machinery ¥684 100 million (YoY -21.3%), Other ¥345 100 million (YoY -12.0%) |
| Segment profit | Functional products ¥98 100 million (YoY -16.4%), High-performance urethane ¥-5 100 million, Pharmaceuticals ¥-13 100 million, Resins and chemicals ¥82 100 million, Machinery ¥62 100 million (YoY -20.8%), Other ¥19 100 million (YoY -6.9%) |
| Regional sales | Region Japan / Current fiscal year ¥206,267 million / Previous period ¥226,017 million, Region Asia / Current fiscal year ¥127,679 million / Previous period ¥138,394 million, Region Europe / Current fiscal year ¥67,352 million / Previous period ¥65,011 million, Region North America / Current fiscal year ¥42,930 million / Previous period ¥38,429 million, Region Other / Current fiscal year ¥18,115 million / Previous period ¥18,951 million |
| Depreciation and amortization | ¥25,687 million |
| Impairment loss | ¥2,699 million |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on sale of non-current assets ¥92 million, Gain on sale of investment securities ¥239 million / Extraordinary loss Losses on disposal of fixed assets ¥746 million, Impairment Losses ¥2,699 million, Impairment loss on investment securities ¥1 million, Loss on affiliated businesses ¥3,660 million |
| Disclosure regarding the going concern assumption | Not applicable. |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New Number of companies 11 / Company name UBE URETHANES AUSTRALIA PTY LTD, UBE LATIN AMERICA LTDA., UBE URETHANES CANADA LTD., UBE China Holding Company Limited, UBE Urethanes Nantong Co., Ltd., UBE Urethanes Germany GmbH, UBE URETHANES INDIA PRIVATE LIMITED, UBE URETHANES ITALY S.R.L, UBE URETHANES Netherlands B.V., UBE URETHANES UK LTD., UBE URETHANES USA LLC / Excluded Not disclosed |
| Material subsequent events | Not applicable. |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Whether applicable Yes / Subject person Analysts and institutional investors |
| Issued Shares at Period-End | 106,200,107 |
| Treasury Shares at Period-End | 9,054,915 |
| Factors Behind Changes in Business Performance | Revenue declined due to weak sales of nylon polymers, caprolactam and other products, and the exclusion of the steelmaking business from the scope of consolidation, despite the contribution from the acquisition of the Urethane Systems business. Operating profit increased due to lower depreciation and amortization resulting from the business structure reform-related impairment loss recorded in the previous fiscal year, the absence of a periodic maintenance shutdown at the ammonia plant, and lower elastomer raw material prices. Net income attributable to owners of the parent increased because the extraordinary losses related to business structure reform recorded in the previous fiscal year did not recur in the current fiscal year. |
Items this document does not state (2)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Revenue declined despite the contribution from the acquisition of the Urethane Systems business, due to weak sales of nylon polymers, caprolactam and other products, as well as the exclusion of the steelmaking business from the scope of consolidation. Operating profit increased due to lower depreciation and amortization resulting from the impairment loss recorded in the previous fiscal year, the absence of the periodic maintenance shutdown conducted every other year, and lower elastomer raw material prices. Net income was significantly boosted by the absence in the current fiscal year of the extraordinary losses related to business structure reform recorded in the previous fiscal year.